Review
Published on 11 May 2023
Herbal medicine for the treatment of obesity-associated asthma: a comprehensive review
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1186060
- 5,164 views
- 3 citations
Type at least 3 characters
571 articles
Articles
Original Research
Published on 05 May 2023
Efficacy of a paper-based interleukin-6 test strip combined with a spectrum-based optical reader for sequential monitoring and early recognition of respiratory failure in elderly pneumonia—a pilot study
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1166923
- 2,024 views
Case Report
Published on 04 May 2023
Case Report: Nintedanib for immune-related pneumonitis triggered by anti-PD-1 treatment in a patient with SMARCA4-mutant NSCLC: a case report
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1177329
- 2,249 views
- 1 citation
Correction
Published on 03 May 2023
Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1207356
- 1,116 views
Original Research
Published on 24 Apr 2023
Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1145994
- 2,636 views
- 2 citations
Original Research
Published on 17 Apr 2023
The performance of metagenomic next-generation sequencing in diagnosing pulmonary infectious diseases using authentic clinical specimens: The Illumina platform versus the Beijing Genomics Institute platform
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1164633
- 1,633 views
- 2 citations
Original Research
Published on 11 Apr 2023
The effect of CFTR modulators on structural lung disease in cystic fibrosis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1147348
- 2,777 views
- 5 citations
Original Research
Published on 10 Apr 2023
Long-term effects of lumacaftor/ivacaftor on paranasal sinus abnormalities in children with cystic fibrosis detected with magnetic resonance imaging
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1161891
- 1,959 views
- 7 citations
Original Research
Published on 04 Apr 2023
Low-dose of caffeine alleviates high altitude pulmonary edema via regulating mitochondrial quality control process in AT1 cells
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1155414
- 3,825 views
Review
Published on 30 Mar 2023
Sex chromosome complement and sex steroid signaling underlie sex differences in immunity to respiratory virus infection
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1150282
- 3,717 views
- 3 citations
Original Research
Published on 29 Mar 2023
Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1021535
- 3,081 views
- 2 citations
Review
Published on 21 Mar 2023
Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor—Ivacaftor
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1158207
- 6,717 views
- 10 citations
Clinical Trial
Published on 21 Mar 2023
Comparison of treatment persistence, adherence, and risk of exacerbation in patients with COPD treated with single-inhaler versus multiple-inhaler triple therapy: A prospective observational study in China
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1147985
- 2,972 views
- 3 citations
Review
Published on 16 Mar 2023
The protective effects of baicalin for respiratory diseases: an update and future perspectives
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1129817
- 6,396 views
- 6 citations
Original Research
Published on 16 Mar 2023
Better response to Tanreqing injection in frequent acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients—Real-world evidence from a nationwide registry (ACURE) study
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1118143
- 2,076 views
- 1 citation
Review
Published on 16 Mar 2023
Functional enhancement strategies to potentiate the therapeutic properties of mesenchymal stromal cells for respiratory diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1067422
- 7,954 views
- 10 citations